Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors
Adjustments follow data such as dose changes, switching peptides, adding supportive therapies like anti-inflammatories, or pausing treatment if adverse events occur
Data reveals it can be helpful for post-injury recovery, surgical healing, and neuroregenerative applications
Scar tissue was assessed using a delayed enhancement inversion-recovery sequence (slice thickness 8 mm, echo time 1.4 ms, field of view 300360 mm, no slice gap
Its also important to note that we do not view peptides as a replacement for orthobiologic treatments like bone marrow concentrate (which contains stem cells) or platelet-rich plasma (PRP)
Eur J Clin Investig